Spiramycin I-d3 (CAS 1355452-20-8)

Spiramycin I-d3 is a deuterated version of Spiramycin I, a macrolide compound, in which three hydrogen atoms are replaced with deuterium. This isotopic substitution enhances the molecule′s stability and alters its physical properties, such as its vibrational profile, without changing its chemical structure. The introduction of deuterium atoms is particularly beneficial in analytical research, where Spiramycin I-d3 is used as an internal standard to improve the accuracy and precision of mass spectrometric analyses. By using this deuterated compound, researchers can differentiate the analyte from similar molecules and reduce background noise, which is crucial in complex biological or environmental matrices where precise quantification is vital. The specific use of Spiramycin I-d3 in research focuses on studying the metabolism and environmental degradation pathways of spiramycin. In these studies, Spiramycin I-d3 helps in delineating and quantifying the biotransformation products of spiramycin under various conditions. Additionally, this compound is employed in environmental science research to track the fate of spiramycin in ecosystems, helping to understand its persistence and the potential for bioaccumulation. Such studies are essential for assessing the environmental impact of bioactive compounds and designing strategies for mitigating their presence in the environment.